CREO Stock Forecast - Creo Medical Group PLC - Alpha Spread

Watchlist Manager

Watchlist

Price: 10.875 GBX Market Closed

Market Cap: £44.9m

Wall Street
Price Targets

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 51 GBX with a low forecast of 40.4 GBX and a high forecast of 73.5 GBX.

CREO Lowest Forecast

Wall Street Target

CREO Average Forecast

Wall Street Target

CREO Highest Forecast

Wall Street Target

271% Upside

369% Upside

576% Upside

Sigdo Koppers SA

0% Upside

Nkarta Inc

419% Upside

Vibhavadi Medical Center PCL

3% Upside

MarineMax Inc

22% Upside

Sigdo Koppers SA

0% Upside

Nkarta Inc

419% Upside

Vibhavadi Medical Center PCL

3% Upside

MarineMax Inc

22% Upside

Revenue
Forecast

N/A

Past Growth

69% / Year

Estimated Growth

Estimates Accuracy

-44%

Average Miss

N/A

Past Growth

69% / Year

Estimated Growth

Estimates Accuracy

-44%

Average Miss

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 4 years is 69%.

What are analyst estimates?

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

16%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

16%

Average Beat

What are analyst estimates?

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-51%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-51%

Average Miss

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for CREO is 51 GBX with a low forecast of 40.4 GBX and a high forecast of 73.5 GBX.

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 4 years is 69%.

Back to Top

Join more than 328,600+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Get AI-powered insights for any company or topic.

Open AI Assistant

Stock Screener

Discover stocks

Stock Comparison

Smarter decisions through side-by-side analysis

Intrinsic Value Calculator

Discover the true worth of your stocks

DCF Value Calculator

Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.